Page 5 - Chris Viehbacher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biogen turning the corner as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO

Biogen turning the corner as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairChris viehbacherLee brownAlisha alaimoWhile biogenNorth americaThird bridge

Biogen to invest more in launch of Alzheimer s drug Leqembi

BioPharma

United statesChris viehbacherAlisha alaimoCenters for medicareMedicaid servicesWall streetNorth american

India s role in medical product space represents both a unique opportunity and an important responsibility: FDA Commissioner

India s role in medical product space represents both a unique opportunity and an important responsibility: FDA Commissioner
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

United statesNew delhiAndhra pradeshRobert plengeHari bhartiaNoubar afeyanGeorge daleyDilip shanghviSun pharmaMarcus schindlerRobert califfChris viehbacherMarc tessier lavigneHarvard medical schoolDrug administrationService award

Amgen CEO nabs pay raise thanks to Horizon deal Does that incentivize aggressive M&A?

Amgen CEO nabs pay raise thanks to Horizon deal Does that incentivize aggressive M&A?
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesAbbvie humiraChris viehbacherRobert bradwayReata pharmaceuticalsUs federal trade commissionTrade commissionFierce pharma

Healthy Returns: The launch of breakthrough Alzheimer s drug Leqembi is off to a slow start

The Alzheimer’s drug Leqembi from Biogen and Eisai is seeing a slow launch, but demand is rising. Meanwhile, headsets are making some users nauseous.

United statesNew yorkJim cramerNatascha tuznikEli lillyJoanna jenTodd haseltonTim cookChris viehbacherMorgan stanleyDrug administrationMount sinai health systemUniversity of californiaWall streetVision pro